nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrazepam—ABCB1—Lisinopril—systemic scleroderma	0.0747	0.272	CbGbCtD
Nitrazepam—ABCB1—Captopril—systemic scleroderma	0.0559	0.203	CbGbCtD
Nitrazepam—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.044	0.16	CbGbCtD
Nitrazepam—ABCB1—Prednisone—systemic scleroderma	0.0352	0.128	CbGbCtD
Nitrazepam—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0264	0.0959	CbGbCtD
Nitrazepam—CYP3A4—Prednisone—systemic scleroderma	0.0211	0.0767	CbGbCtD
Nitrazepam—ABCB1—Methotrexate—systemic scleroderma	0.0177	0.0642	CbGbCtD
Nitrazepam—Vision blurred—Leflunomide—systemic scleroderma	0.00186	0.00257	CcSEcCtD
Nitrazepam—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00186	0.00256	CcSEcCtD
Nitrazepam—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00256	CcSEcCtD
Nitrazepam—Asthenia—Pentoxifylline—systemic scleroderma	0.00185	0.00255	CcSEcCtD
Nitrazepam—Tension—Mycophenolic acid—systemic scleroderma	0.00185	0.00255	CcSEcCtD
Nitrazepam—Nervousness—Mycophenolic acid—systemic scleroderma	0.00183	0.00252	CcSEcCtD
Nitrazepam—Hypotension—Captopril—systemic scleroderma	0.00183	0.00252	CcSEcCtD
Nitrazepam—Pruritus—Pentoxifylline—systemic scleroderma	0.00182	0.00252	CcSEcCtD
Nitrazepam—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00251	CcSEcCtD
Nitrazepam—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00181	0.0025	CcSEcCtD
Nitrazepam—Amnesia—Prednisone—systemic scleroderma	0.00178	0.00246	CcSEcCtD
Nitrazepam—Malaise—Leflunomide—systemic scleroderma	0.00178	0.00246	CcSEcCtD
Nitrazepam—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00177	0.00245	CcSEcCtD
Nitrazepam—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00245	CcSEcCtD
Nitrazepam—Vertigo—Leflunomide—systemic scleroderma	0.00177	0.00245	CcSEcCtD
Nitrazepam—Leukopenia—Leflunomide—systemic scleroderma	0.00177	0.00244	CcSEcCtD
Nitrazepam—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00176	0.00243	CcSEcCtD
Nitrazepam—Tremor—Mycophenolic acid—systemic scleroderma	0.00176	0.00243	CcSEcCtD
Nitrazepam—Paraesthesia—Captopril—systemic scleroderma	0.00175	0.00242	CcSEcCtD
Nitrazepam—Palpitations—Leflunomide—systemic scleroderma	0.00174	0.00241	CcSEcCtD
Nitrazepam—Dyspnoea—Captopril—systemic scleroderma	0.00174	0.0024	CcSEcCtD
Nitrazepam—Somnolence—Captopril—systemic scleroderma	0.00174	0.0024	CcSEcCtD
Nitrazepam—Agitation—Mycophenolic acid—systemic scleroderma	0.00173	0.00239	CcSEcCtD
Nitrazepam—Dyspepsia—Captopril—systemic scleroderma	0.00172	0.00237	CcSEcCtD
Nitrazepam—Lethargy—Prednisone—systemic scleroderma	0.00171	0.00235	CcSEcCtD
Nitrazepam—Dizziness—Pentoxifylline—systemic scleroderma	0.00171	0.00235	CcSEcCtD
Nitrazepam—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00234	CcSEcCtD
Nitrazepam—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00234	CcSEcCtD
Nitrazepam—Malaise—Mycophenolic acid—systemic scleroderma	0.0017	0.00234	CcSEcCtD
Nitrazepam—Infection—Azathioprine—systemic scleroderma	0.00169	0.00234	CcSEcCtD
Nitrazepam—Vertigo—Mycophenolic acid—systemic scleroderma	0.00169	0.00233	CcSEcCtD
Nitrazepam—Syncope—Mycophenolic acid—systemic scleroderma	0.00169	0.00233	CcSEcCtD
Nitrazepam—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00169	0.00232	CcSEcCtD
Nitrazepam—Fatigue—Captopril—systemic scleroderma	0.00168	0.00232	CcSEcCtD
Nitrazepam—Anxiety—Leflunomide—systemic scleroderma	0.00167	0.00231	CcSEcCtD
Nitrazepam—Constipation—Captopril—systemic scleroderma	0.00167	0.00231	CcSEcCtD
Nitrazepam—Tension—Lisinopril—systemic scleroderma	0.00166	0.0023	CcSEcCtD
Nitrazepam—Palpitations—Mycophenolic acid—systemic scleroderma	0.00166	0.0023	CcSEcCtD
Nitrazepam—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00165	0.00228	CcSEcCtD
Nitrazepam—Nervousness—Lisinopril—systemic scleroderma	0.00165	0.00227	CcSEcCtD
Nitrazepam—Vomiting—Pentoxifylline—systemic scleroderma	0.00164	0.00226	CcSEcCtD
Nitrazepam—Psychotic disorder—Prednisone—systemic scleroderma	0.00163	0.00225	CcSEcCtD
Nitrazepam—Convulsion—Mycophenolic acid—systemic scleroderma	0.00163	0.00225	CcSEcCtD
Nitrazepam—Muscle spasms—Lisinopril—systemic scleroderma	0.00163	0.00225	CcSEcCtD
Nitrazepam—Rash—Pentoxifylline—systemic scleroderma	0.00163	0.00224	CcSEcCtD
Nitrazepam—Dermatitis—Pentoxifylline—systemic scleroderma	0.00162	0.00224	CcSEcCtD
Nitrazepam—Headache—Pentoxifylline—systemic scleroderma	0.00162	0.00223	CcSEcCtD
Nitrazepam—Feeling abnormal—Captopril—systemic scleroderma	0.00161	0.00222	CcSEcCtD
Nitrazepam—Infection—Leflunomide—systemic scleroderma	0.0016	0.00221	CcSEcCtD
Nitrazepam—Vision blurred—Lisinopril—systemic scleroderma	0.0016	0.0022	CcSEcCtD
Nitrazepam—Anxiety—Mycophenolic acid—systemic scleroderma	0.0016	0.0022	CcSEcCtD
Nitrazepam—Asthenia—Mometasone—systemic scleroderma	0.0016	0.0022	CcSEcCtD
Nitrazepam—Irritability—Prednisone—systemic scleroderma	0.0016	0.0022	CcSEcCtD
Nitrazepam—Hypotension—Azathioprine—systemic scleroderma	0.00159	0.0022	CcSEcCtD
Nitrazepam—Tremor—Lisinopril—systemic scleroderma	0.00159	0.00219	CcSEcCtD
Nitrazepam—Pruritus—Mometasone—systemic scleroderma	0.00157	0.00217	CcSEcCtD
Nitrazepam—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00156	0.00215	CcSEcCtD
Nitrazepam—Confusional state—Mycophenolic acid—systemic scleroderma	0.00155	0.00214	CcSEcCtD
Nitrazepam—Nausea—Pentoxifylline—systemic scleroderma	0.00153	0.00211	CcSEcCtD
Nitrazepam—Malaise—Lisinopril—systemic scleroderma	0.00153	0.00211	CcSEcCtD
Nitrazepam—Infection—Mycophenolic acid—systemic scleroderma	0.00153	0.00211	CcSEcCtD
Nitrazepam—Vertigo—Lisinopril—systemic scleroderma	0.00152	0.0021	CcSEcCtD
Nitrazepam—Diarrhoea—Mometasone—systemic scleroderma	0.00152	0.0021	CcSEcCtD
Nitrazepam—Syncope—Lisinopril—systemic scleroderma	0.00152	0.0021	CcSEcCtD
Nitrazepam—Leukopenia—Lisinopril—systemic scleroderma	0.00152	0.00209	CcSEcCtD
Nitrazepam—Shock—Mycophenolic acid—systemic scleroderma	0.00151	0.00209	CcSEcCtD
Nitrazepam—Hypotension—Leflunomide—systemic scleroderma	0.00151	0.00208	CcSEcCtD
Nitrazepam—Palpitations—Lisinopril—systemic scleroderma	0.0015	0.00207	CcSEcCtD
Nitrazepam—Loss of consciousness—Lisinopril—systemic scleroderma	0.00149	0.00206	CcSEcCtD
Nitrazepam—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00149	0.00205	CcSEcCtD
Nitrazepam—Muscular weakness—Prednisone—systemic scleroderma	0.00148	0.00203	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00147	0.00203	CcSEcCtD
Nitrazepam—Tension—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00201	CcSEcCtD
Nitrazepam—Paraesthesia—Leflunomide—systemic scleroderma	0.00145	0.002	CcSEcCtD
Nitrazepam—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00199	CcSEcCtD
Nitrazepam—Anxiety—Lisinopril—systemic scleroderma	0.00144	0.00198	CcSEcCtD
Nitrazepam—Dyspnoea—Leflunomide—systemic scleroderma	0.00144	0.00198	CcSEcCtD
Nitrazepam—Hypotension—Mycophenolic acid—systemic scleroderma	0.00144	0.00198	CcSEcCtD
Nitrazepam—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00197	CcSEcCtD
Nitrazepam—Lethargy—Methotrexate—systemic scleroderma	0.00143	0.00197	CcSEcCtD
Nitrazepam—Dyspepsia—Leflunomide—systemic scleroderma	0.00142	0.00196	CcSEcCtD
Nitrazepam—Vomiting—Mometasone—systemic scleroderma	0.00141	0.00195	CcSEcCtD
Nitrazepam—Feeling abnormal—Azathioprine—systemic scleroderma	0.00141	0.00194	CcSEcCtD
Nitrazepam—Rash—Mometasone—systemic scleroderma	0.0014	0.00194	CcSEcCtD
Nitrazepam—Asthenia—Captopril—systemic scleroderma	0.0014	0.00193	CcSEcCtD
Nitrazepam—Dermatitis—Mometasone—systemic scleroderma	0.0014	0.00193	CcSEcCtD
Nitrazepam—Confusional state—Lisinopril—systemic scleroderma	0.0014	0.00193	CcSEcCtD
Nitrazepam—Headache—Mometasone—systemic scleroderma	0.00139	0.00192	CcSEcCtD
Nitrazepam—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00192	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00139	0.00192	CcSEcCtD
Nitrazepam—Fatigue—Leflunomide—systemic scleroderma	0.00139	0.00192	CcSEcCtD
Nitrazepam—Pruritus—Captopril—systemic scleroderma	0.00138	0.00191	CcSEcCtD
Nitrazepam—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00138	0.0019	CcSEcCtD
Nitrazepam—Constipation—Leflunomide—systemic scleroderma	0.00138	0.0019	CcSEcCtD
Nitrazepam—Infection—Lisinopril—systemic scleroderma	0.00138	0.0019	CcSEcCtD
Nitrazepam—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00137	0.00189	CcSEcCtD
Nitrazepam—Somnolence—Mycophenolic acid—systemic scleroderma	0.00137	0.00188	CcSEcCtD
Nitrazepam—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00137	0.00188	CcSEcCtD
Nitrazepam—Shock—Lisinopril—systemic scleroderma	0.00136	0.00188	CcSEcCtD
Nitrazepam—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00135	0.00187	CcSEcCtD
Nitrazepam—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00185	CcSEcCtD
Nitrazepam—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00134	0.00185	CcSEcCtD
Nitrazepam—Diarrhoea—Captopril—systemic scleroderma	0.00134	0.00184	CcSEcCtD
Nitrazepam—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00184	CcSEcCtD
Nitrazepam—Irritability—Methotrexate—systemic scleroderma	0.00133	0.00184	CcSEcCtD
Nitrazepam—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00184	CcSEcCtD
Nitrazepam—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00133	0.00183	CcSEcCtD
Nitrazepam—Feeling abnormal—Leflunomide—systemic scleroderma	0.00133	0.00183	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00133	0.00183	CcSEcCtD
Nitrazepam—Fatigue—Mycophenolic acid—systemic scleroderma	0.00132	0.00183	CcSEcCtD
Nitrazepam—Nausea—Mometasone—systemic scleroderma	0.00132	0.00182	CcSEcCtD
Nitrazepam—Ataxia—Methotrexate—systemic scleroderma	0.00131	0.00181	CcSEcCtD
Nitrazepam—Constipation—Mycophenolic acid—systemic scleroderma	0.00131	0.00181	CcSEcCtD
Nitrazepam—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00181	CcSEcCtD
Nitrazepam—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00131	0.0018	CcSEcCtD
Nitrazepam—Hypotension—Lisinopril—systemic scleroderma	0.00129	0.00178	CcSEcCtD
Nitrazepam—Dizziness—Captopril—systemic scleroderma	0.00129	0.00178	CcSEcCtD
Nitrazepam—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00178	CcSEcCtD
Nitrazepam—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00127	0.00175	CcSEcCtD
Nitrazepam—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00174	CcSEcCtD
Nitrazepam—Hypersensitivity—Azathioprine—systemic scleroderma	0.00126	0.00173	CcSEcCtD
Nitrazepam—Paraesthesia—Lisinopril—systemic scleroderma	0.00124	0.00171	CcSEcCtD
Nitrazepam—Vomiting—Captopril—systemic scleroderma	0.00124	0.00171	CcSEcCtD
Nitrazepam—Dyspnoea—Lisinopril—systemic scleroderma	0.00123	0.0017	CcSEcCtD
Nitrazepam—Rash—Captopril—systemic scleroderma	0.00123	0.0017	CcSEcCtD
Nitrazepam—Dermatitis—Captopril—systemic scleroderma	0.00123	0.0017	CcSEcCtD
Nitrazepam—Somnolence—Lisinopril—systemic scleroderma	0.00123	0.0017	CcSEcCtD
Nitrazepam—Headache—Captopril—systemic scleroderma	0.00122	0.00169	CcSEcCtD
Nitrazepam—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00169	CcSEcCtD
Nitrazepam—Dyspepsia—Lisinopril—systemic scleroderma	0.00122	0.00168	CcSEcCtD
Nitrazepam—Infection—Mycophenolate mofetil—systemic scleroderma	0.0012	0.00166	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00119	0.00165	CcSEcCtD
Nitrazepam—Fatigue—Lisinopril—systemic scleroderma	0.00119	0.00165	CcSEcCtD
Nitrazepam—Shock—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00165	CcSEcCtD
Nitrazepam—Hypersensitivity—Leflunomide—systemic scleroderma	0.00119	0.00164	CcSEcCtD
Nitrazepam—Constipation—Lisinopril—systemic scleroderma	0.00118	0.00163	CcSEcCtD
Nitrazepam—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00162	CcSEcCtD
Nitrazepam—Diarrhoea—Azathioprine—systemic scleroderma	0.00117	0.00161	CcSEcCtD
Nitrazepam—Nausea—Captopril—systemic scleroderma	0.00116	0.0016	CcSEcCtD
Nitrazepam—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00116	0.0016	CcSEcCtD
Nitrazepam—Asthenia—Leflunomide—systemic scleroderma	0.00116	0.00159	CcSEcCtD
Nitrazepam—Hallucination—Prednisone—systemic scleroderma	0.00115	0.00159	CcSEcCtD
Nitrazepam—Feeling abnormal—Lisinopril—systemic scleroderma	0.00114	0.00157	CcSEcCtD
Nitrazepam—Pruritus—Leflunomide—systemic scleroderma	0.00114	0.00157	CcSEcCtD
Nitrazepam—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00156	CcSEcCtD
Nitrazepam—Dizziness—Azathioprine—systemic scleroderma	0.00113	0.00156	CcSEcCtD
Nitrazepam—Asthenia—Mycophenolic acid—systemic scleroderma	0.0011	0.00152	CcSEcCtD
Nitrazepam—Diarrhoea—Leflunomide—systemic scleroderma	0.0011	0.00152	CcSEcCtD
Nitrazepam—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00109	0.0015	CcSEcCtD
Nitrazepam—Pruritus—Mycophenolic acid—systemic scleroderma	0.00109	0.0015	CcSEcCtD
Nitrazepam—Vomiting—Azathioprine—systemic scleroderma	0.00108	0.0015	CcSEcCtD
Nitrazepam—Pneumonia—Methotrexate—systemic scleroderma	0.00108	0.00149	CcSEcCtD
Nitrazepam—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00149	CcSEcCtD
Nitrazepam—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00149	CcSEcCtD
Nitrazepam—Drowsiness—Methotrexate—systemic scleroderma	0.00108	0.00149	CcSEcCtD
Nitrazepam—Rash—Azathioprine—systemic scleroderma	0.00108	0.00148	CcSEcCtD
Nitrazepam—Dermatitis—Azathioprine—systemic scleroderma	0.00107	0.00148	CcSEcCtD
Nitrazepam—Headache—Azathioprine—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Nitrazepam—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Nitrazepam—Dizziness—Leflunomide—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Nitrazepam—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00105	0.00145	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00144	CcSEcCtD
Nitrazepam—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00143	CcSEcCtD
Nitrazepam—Sweating—Methotrexate—systemic scleroderma	0.00103	0.00142	CcSEcCtD
Nitrazepam—Vomiting—Leflunomide—systemic scleroderma	0.00102	0.00141	CcSEcCtD
Nitrazepam—Hypersensitivity—Lisinopril—systemic scleroderma	0.00102	0.00141	CcSEcCtD
Nitrazepam—Dizziness—Mycophenolic acid—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Nitrazepam—Rash—Leflunomide—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Nitrazepam—Dermatitis—Leflunomide—systemic scleroderma	0.00101	0.0014	CcSEcCtD
Nitrazepam—Nausea—Azathioprine—systemic scleroderma	0.00101	0.0014	CcSEcCtD
Nitrazepam—Headache—Leflunomide—systemic scleroderma	0.00101	0.00139	CcSEcCtD
Nitrazepam—Agranulocytosis—Methotrexate—systemic scleroderma	0.00101	0.00139	CcSEcCtD
Nitrazepam—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000999	0.00138	CcSEcCtD
Nitrazepam—Asthenia—Lisinopril—systemic scleroderma	0.000993	0.00137	CcSEcCtD
Nitrazepam—Pruritus—Lisinopril—systemic scleroderma	0.000979	0.00135	CcSEcCtD
Nitrazepam—Vomiting—Mycophenolic acid—systemic scleroderma	0.000977	0.00135	CcSEcCtD
Nitrazepam—Rash—Mycophenolic acid—systemic scleroderma	0.000969	0.00134	CcSEcCtD
Nitrazepam—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000968	0.00134	CcSEcCtD
Nitrazepam—Headache—Mycophenolic acid—systemic scleroderma	0.000963	0.00133	CcSEcCtD
Nitrazepam—Nausea—Leflunomide—systemic scleroderma	0.000957	0.00132	CcSEcCtD
Nitrazepam—Vision blurred—Prednisone—systemic scleroderma	0.000949	0.00131	CcSEcCtD
Nitrazepam—Diarrhoea—Lisinopril—systemic scleroderma	0.000947	0.00131	CcSEcCtD
Nitrazepam—Agitation—Prednisone—systemic scleroderma	0.000926	0.00128	CcSEcCtD
Nitrazepam—Dizziness—Lisinopril—systemic scleroderma	0.000915	0.00126	CcSEcCtD
Nitrazepam—Nausea—Mycophenolic acid—systemic scleroderma	0.000913	0.00126	CcSEcCtD
Nitrazepam—Malaise—Prednisone—systemic scleroderma	0.000908	0.00125	CcSEcCtD
Nitrazepam—Vertigo—Prednisone—systemic scleroderma	0.000905	0.00125	CcSEcCtD
Nitrazepam—Syncope—Prednisone—systemic scleroderma	0.000903	0.00125	CcSEcCtD
Nitrazepam—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000893	0.00123	CcSEcCtD
Nitrazepam—Loss of consciousness—Prednisone—systemic scleroderma	0.000885	0.00122	CcSEcCtD
Nitrazepam—Vomiting—Lisinopril—systemic scleroderma	0.00088	0.00121	CcSEcCtD
Nitrazepam—Rash—Lisinopril—systemic scleroderma	0.000873	0.0012	CcSEcCtD
Nitrazepam—Convulsion—Prednisone—systemic scleroderma	0.000873	0.0012	CcSEcCtD
Nitrazepam—Dermatitis—Lisinopril—systemic scleroderma	0.000872	0.0012	CcSEcCtD
Nitrazepam—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00087	0.0012	CcSEcCtD
Nitrazepam—Headache—Lisinopril—systemic scleroderma	0.000867	0.0012	CcSEcCtD
Nitrazepam—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000858	0.00118	CcSEcCtD
Nitrazepam—Anxiety—Prednisone—systemic scleroderma	0.000855	0.00118	CcSEcCtD
Nitrazepam—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00083	0.00114	CcSEcCtD
Nitrazepam—Nausea—Lisinopril—systemic scleroderma	0.000822	0.00113	CcSEcCtD
Nitrazepam—Infection—Prednisone—systemic scleroderma	0.000817	0.00113	CcSEcCtD
Nitrazepam—Shock—Prednisone—systemic scleroderma	0.000809	0.00112	CcSEcCtD
Nitrazepam—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000802	0.00111	CcSEcCtD
Nitrazepam—Hyperhidrosis—Prednisone—systemic scleroderma	0.000795	0.0011	CcSEcCtD
Nitrazepam—Vision blurred—Methotrexate—systemic scleroderma	0.000793	0.00109	CcSEcCtD
Nitrazepam—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000771	0.00106	CcSEcCtD
Nitrazepam—Rash—Mycophenolate mofetil—systemic scleroderma	0.000765	0.00105	CcSEcCtD
Nitrazepam—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000764	0.00105	CcSEcCtD
Nitrazepam—Headache—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00105	CcSEcCtD
Nitrazepam—Malaise—Methotrexate—systemic scleroderma	0.000759	0.00105	CcSEcCtD
Nitrazepam—Vertigo—Methotrexate—systemic scleroderma	0.000756	0.00104	CcSEcCtD
Nitrazepam—Leukopenia—Methotrexate—systemic scleroderma	0.000753	0.00104	CcSEcCtD
Nitrazepam—Paraesthesia—Prednisone—systemic scleroderma	0.000738	0.00102	CcSEcCtD
Nitrazepam—Convulsion—Methotrexate—systemic scleroderma	0.000729	0.00101	CcSEcCtD
Nitrazepam—Dyspepsia—Prednisone—systemic scleroderma	0.000724	0.000998	CcSEcCtD
Nitrazepam—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00072	0.000994	CcSEcCtD
Nitrazepam—Fatigue—Prednisone—systemic scleroderma	0.000709	0.000978	CcSEcCtD
Nitrazepam—Constipation—Prednisone—systemic scleroderma	0.000703	0.00097	CcSEcCtD
Nitrazepam—Confusional state—Methotrexate—systemic scleroderma	0.000693	0.000956	CcSEcCtD
Nitrazepam—Infection—Methotrexate—systemic scleroderma	0.000682	0.000942	CcSEcCtD
Nitrazepam—Feeling abnormal—Prednisone—systemic scleroderma	0.000677	0.000934	CcSEcCtD
Nitrazepam—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000664	0.000916	CcSEcCtD
Nitrazepam—Hypotension—Methotrexate—systemic scleroderma	0.000642	0.000886	CcSEcCtD
Nitrazepam—Paraesthesia—Methotrexate—systemic scleroderma	0.000617	0.000851	CcSEcCtD
Nitrazepam—Dyspnoea—Methotrexate—systemic scleroderma	0.000612	0.000845	CcSEcCtD
Nitrazepam—Somnolence—Methotrexate—systemic scleroderma	0.000611	0.000843	CcSEcCtD
Nitrazepam—Hypersensitivity—Prednisone—systemic scleroderma	0.000606	0.000835	CcSEcCtD
Nitrazepam—Dyspepsia—Methotrexate—systemic scleroderma	0.000605	0.000834	CcSEcCtD
Nitrazepam—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000593	0.000818	CcSEcCtD
Nitrazepam—Fatigue—Methotrexate—systemic scleroderma	0.000592	0.000817	CcSEcCtD
Nitrazepam—Asthenia—Prednisone—systemic scleroderma	0.00059	0.000814	CcSEcCtD
Nitrazepam—Pruritus—Prednisone—systemic scleroderma	0.000582	0.000802	CcSEcCtD
Nitrazepam—Feeling abnormal—Methotrexate—systemic scleroderma	0.000566	0.000781	CcSEcCtD
Nitrazepam—Diarrhoea—Prednisone—systemic scleroderma	0.000562	0.000776	CcSEcCtD
Nitrazepam—Dizziness—Prednisone—systemic scleroderma	0.000544	0.00075	CcSEcCtD
Nitrazepam—Vomiting—Prednisone—systemic scleroderma	0.000523	0.000721	CcSEcCtD
Nitrazepam—Rash—Prednisone—systemic scleroderma	0.000518	0.000715	CcSEcCtD
Nitrazepam—Dermatitis—Prednisone—systemic scleroderma	0.000518	0.000714	CcSEcCtD
Nitrazepam—Headache—Prednisone—systemic scleroderma	0.000515	0.00071	CcSEcCtD
Nitrazepam—Hypersensitivity—Methotrexate—systemic scleroderma	0.000506	0.000698	CcSEcCtD
Nitrazepam—Asthenia—Methotrexate—systemic scleroderma	0.000493	0.00068	CcSEcCtD
Nitrazepam—Nausea—Prednisone—systemic scleroderma	0.000488	0.000674	CcSEcCtD
Nitrazepam—Pruritus—Methotrexate—systemic scleroderma	0.000486	0.00067	CcSEcCtD
Nitrazepam—Diarrhoea—Methotrexate—systemic scleroderma	0.00047	0.000648	CcSEcCtD
Nitrazepam—Dizziness—Methotrexate—systemic scleroderma	0.000454	0.000627	CcSEcCtD
Nitrazepam—Vomiting—Methotrexate—systemic scleroderma	0.000437	0.000603	CcSEcCtD
Nitrazepam—Rash—Methotrexate—systemic scleroderma	0.000433	0.000598	CcSEcCtD
Nitrazepam—Dermatitis—Methotrexate—systemic scleroderma	0.000433	0.000597	CcSEcCtD
Nitrazepam—Headache—Methotrexate—systemic scleroderma	0.00043	0.000594	CcSEcCtD
Nitrazepam—Nausea—Methotrexate—systemic scleroderma	0.000408	0.000563	CcSEcCtD
